Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Salivary gland tumours
2002599 citationsPM Speight, AW BarrettOral Diseasesprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of PM Speight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by PM Speight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites PM Speight more than expected).
This network shows the impact of papers produced by PM Speight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by PM Speight. The network helps show where PM Speight may publish in the future.
Co-authorship network of co-authors of PM Speight
This figure shows the co-authorship network connecting the top 25 collaborators of PM Speight.
A scholar is included among the top collaborators of PM Speight based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with PM Speight. PM Speight is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Morgan, et al.. (2001). αVβ6 integrin promotes invasion of squamous carcinoma cells through up-regulation of MMP-9. UCL Discovery (University College London).3 indexed citations
7.
Speight, PM, et al.. (1998). An interim determination of health gain from oral cancer and precancer screening: 3. Preselecting high risk individuals.. PubMed. 15(2). 72–6.27 indexed citations
Zakrzewska, Joanna M., et al.. (1995). Evaluation of health care workers' accuracy in recognising oral cancer and precancer. UCL Discovery (University College London).2 indexed citations
Speight, PM, et al.. (1993). Cost and value considerations in screening for oral cancer and precancer.. PubMed. 10 Suppl 1. 71–8.10 indexed citations
13.
Zakrzewska, Joanna M., I Hindle, & PM Speight. (1993). Practical considerations for the establishment of an oral cancer screening programme.. PubMed. 10 Suppl 1. 79–85.18 indexed citations
14.
Speight, PM, et al.. (1993). Screening for Oral Cancer and Precancer. A report of the UK Working Group on Screening for Oral Cancer and Precancer.18 indexed citations
15.
Diss, TC, et al.. (1992). Immunoglobulin gene rearrangement in low grade B-cell MALT lymphomas of salivary gland myoepithelial sialadenitis and Sjogren's syndrome. UCL Discovery (University College London).3 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.